RANKL is the focus of these events, and previous studies have also reported dysregulation of the RANKL/RANK/OPG system in a number of cancers; the levels of these components appear to be associated with various tumor characteristics[37], [38]. This evidence concerns the gene TNFSF11 and cancer.